BAC vs DHC Stock Comparison
BAC currently leads DHC in this stock comparison, with AIQ scores of 47 vs 46. The clearest difference is quality, while DHC has the stronger momentum profile.
What is the main difference between BAC and DHC?
BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Bank of America Corporation vs Diversified Healthcare Trust
BAC leads
BAC leads by 1 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 6 points over 30 sessions.
Fragile: 3 of 6 evidence groups support BAC, its lead is narrowing, and its signal state is cleanly positive.
Bank of America Corporation
Diversified Healthcare Trust
The Algovestiq AIQ Score currently favors BAC over DHC, 47 versus 46 as of Oct 31, 2026. BAC's advantage is driven primarily by stronger quality and risk resilience, while DHC holds the stronger momentum profile. BAC also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. BAC lead: Weakening — the AIQ differential moved from 6 to 1 points over 30 sessions.
Compare Bank of America Corporation and Diversified Healthcare Trust across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BAC and DHC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum26 vs 69DHC +43
- Quality49 vs 7BAC +42
- Risk Resilience60 vs 46BAC +14
- Value57 vs 65DHC +8
3 of 6 evidence groups favor BAC. BAC’s edge is concentrated in quality and risk resilience; DHC keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Risk Resilience +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
Largest factor move: Momentum +13
New signals
- Uptrend Structure Active — bullish, trend, long horizon
BAC's lead narrowed by 4 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — BAC and DHC both carry a full feed there.
The central trade-off
BAC (Bank of America Corporation): the stronger current systematic profile, led by quality and risk resilience.
DHC (Diversified Healthcare Trust): the counter-case, on momentum, value, valuation — but at materially higher volatility, 27.6% against 20.8%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BACBAC on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
DHCDHC on combined revenue and EPS growth.
Value
DHCDHC on the peer-relative Value factor, by 8 points.
Momentum
DHCDHC on the Momentum factor, by 43 points.
Lower downside
BACBAC on Risk Resilience, by 14 points.
Analyst upside
BACBAC on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BAC | DHC | Note |
|---|---|---|---|
| Implied upside to target | +32.5% | +22.1% | BAC has more room |
| Target dispersion | +22.6% | +26.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 2 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | BAC | DHC |
|---|---|---|
| 5Y dividend CAGR | 8.45% | -25.98% |
| 2020 regular DPS | $0.720 | $0.180 |
| 2025 regular DPS | $1.080 | $0.040 |
| Years increased | 5 | 0 |
| No cut in window | Yes | No (1) |
| Cohort rank | #133 | not ranked |
BAC grew its split-adjusted regular dividend faster over 2020–2025 — 8.45% a year against DHC's -25.98%. BAC never reduced its regular dividend in the window; DHC did in 1 year. They are ranked in different cohorts — US dividend-paying corporations and REITs — so their ranks are not comparable with each other.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 47 vs 46 |
| Fundamentals | BACon balance | EPS growth -23.8% vs 11.1%; TTM ROE 10.7% vs -16.2%; gross margin 60.4% vs -5.2%; operating margin 22.4% vs -2.1% — BAC takes 3 of 4 decided legs, not all of them |
| Valuation | DHC | Value 57 vs 65 |
| Technicals | DHC | Price vs 50-day -12.1% vs 0%; vs 200-day -7.5% vs 0.7% |
| Risk Resilience | BAC | Risk Resilience 60 vs 46 |
| Analyst expectations | BAC | Target upside 32.5% vs 22.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and DHC and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28BAC lead: Weakening — the AIQ differential moved from 6 to 1 points over 30 sessions.
- Today
- BAC +1
- 47 vs 46
- 7 sessions ago
- BAC +1
- 47 vs 46
- 30 sessions ago
- BAC +6
- 41 vs 35
- 90 sessions ago
- BAC +15
- 50 vs 35
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon
3 bullish / 0 bearish
Only DHC
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, MACD Bullish Crossover.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.21%, AIQ 0 points).
Price is down while the AIQ Score moved up 4 points over the same session — price and model disagree (price -2.38%, AIQ +4 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DHC closes the Quality gap — currently 42 points behind, the largest single contributor to BAC's edge.
- 2DHC generates a confirmed bullish trend signal it does not currently carry, such as EMA Ribbon Expansion Bullish.
- 3BAC's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4The narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 1-point move would eliminate BAC's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BAC leads on balance| Metric | BAC | DHC |
|---|---|---|
| Revenue growth (YoY) | -3.3% | -0.3% |
| EPS growth (YoY) | -23.8% | 11.1% |
| Gross margin | 60.4% | -5.2% |
| Operating margin | 22.4% | -2.1% |
| Return on equity (TTM) | 10.7% | -16.2% |
| Debt to equity | 1.28 | 1.53 |
Performance
DHC leads 6 of 6 windows| Metric | BAC | DHC |
|---|---|---|
| 1 week (5 sessions) | 0.1% | 1.4% |
| 1 month (20 sessions) | -6.6% | -0.6% |
| 3 months (63 sessions) | -17.6% | -13% |
| 6 months (126 sessions) | -3.8% | 3% |
| Year to date | -7.5% | 60.8% |
| 1 year (252 sessions) | -3.3% | 81.4% |
Technicals
DHC has the stronger structure| Metric | BAC | DHC |
|---|---|---|
| RSI (14) | 31.2 | 58.9 |
| ADX (14) | 49.4 | 17.8 |
| Price vs 50-day | -12.1% | 0% |
| Price vs 200-day | -7.5% | 0.7% |
| Volatility (1M, annualized) | 20.8% | 27.6% |
Risk
BAC is the more resilient| Metric | BAC | DHC |
|---|---|---|
| Beta | 0.73 | 0.54 |
| Sharpe ratio | -0.25 | 1.73 |
| Sortino ratio | -0.32 | 3.05 |
| Max drawdown | -22.3% | -23.6% |
| Current drawdown | -21.5% | -19.1% |
| Annualized volatility | 21.8% | 38.2% |
| Value at risk (95%) | -2.5% | -3.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BAC or DHC?
On the Algovestiq AIQ Score, BAC is the stronger of the two as of Oct 31, 2026, scoring 47 against DHC's 46. The edge comes from quality and risk resilience. DHC is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BAC or DHC the better buy right now?
BAC carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor BAC over DHC?
The composite weights Quality, Value, Momentum and Risk Resilience. DHC leads Momentum by 43 points; BAC leads Quality by 42 points; BAC leads Risk Resilience by 14 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BAC or DHC?
Analyst price targets imply +32.5% upside for BAC and +22.1% for DHC, so the Street currently favors BAC. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BAC or DHC?
DHC is the better-valued of the two on the peer-relative Value factor. DHC on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BAC or DHC?
DHC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BAC or DHC?
DHC on the Momentum factor, by 43 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BAC or DHC?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BAC more profitable than DHC?
BAC leads on the comparable margin measures — gross margin 60.4% vs -5.2%; operating margin 22.4% vs -2.1%; ttm roe 10.7% vs -16.2%.
Is BAC's lead over DHC getting stronger or weaker?
BAC lead: Weakening — the AIQ differential moved from 6 to 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has not changed hands in that window.
What would change the BAC vs DHC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DHC closes the Quality gap — currently 42 points behind, the largest single contributor to BAC's edge; DHC generates a confirmed bullish trend signal it does not currently carry, such as EMA Ribbon Expansion Bullish; BAC's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 1-point move would eliminate BAC's advantage entirely.
What do the current signals say about BAC and DHC?
BAC: 2 bullish / 0 bearish / 1 neutral. DHC: 3 bullish / 0 bearish. The most decision-relevant rule on BAC is Golden Cross Active (bullish, long horizon). On DHC it is Golden Cross Active (bullish, long horizon).
Compare BAC and DHC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.